The RIPPLE AT-PLUS Study

计划入组 201 人 · 首次发布于 2019 年 4 月 16 日

Rituximab and Pegylated Interferon α-2b in Patients With Indolent B-cell Lymphoma

计划入组 52 人 · 首次发布于 2020 年 1 月 29 日

Ripple Mapping Guided Ablation of Ischaemic Ventricular Tachycardia.

计划入组 50 人 · 首次发布于 2019 年 6 月 25 日

Apple

Triple-R

bifid-triple viable

LIVZON PHARMA

China

RIPPE, JAMES MD

United States

Triple-Gene LLC

United States

Bausch + Lomb Partners with Ripple Therapeutics to Develop Polymer-Free Sustained-Release Ophthalmic Implants

SonoThera's Ultrasound Gene Therapy Achieves 65% Normal Factor VIII Levels in Hemophilia A Primate Study

VA Hospital Clinical Trials Suspended Due to DOGE Cuts, Creating Healthcare Crisis for Veterans